ALB and chronic kidney disease: The group treated with rosuvastatin MTD had no significant difference in the concentrations of BUN (12, IQR 11–12 vs 23, IQR 18–31; P ═ 0.148), serum creatinine (75, IQR 73–78 vs 84, IQR 75–87; P ═ 0.72), urine albumin (12.3, IQR 7.8–15.1 vs 12.8, IQR 9.4–14.2; P ═ 0.906), and eGFR (37, IQR 35–39 vs 24, IQR 19–31; P ═ 0.483) compared to the CKD control group.